Mode
Text Size
Log in / Sign up
N/A N=321 Randomized Treatment

Remote Ischemic Preconditioning in Neurological Death Organ Donors

Organ Transplantation

Enrolled (actual)
321
Serious AEs
14.4%
Results posted
Jun 2017
Primary outcome: Primary: Number of Organs Recovered Per Donor — 3.79; 3.60 organs recovered per donor — p=0.38

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
RIPC (Remote Ischemic Preconditioning) (Other)
Age
Pediatric, Adult, Older Adult · 6+ yrs
Sex
All
Sponsor
Rutgers, The State University of New Jersey
Primary completion
Jul 2014

Outcome Measures

OutcomeResultp-value
PRIMARY
Number of Organs Recovered Per Donor
3.79; 3.60 0.38
SECONDARY
Number of Organs Transplanted Per Donor
3.41; 3.31 0.70
SECONDARY
Change in Vasopressor Score
-15.60; -6.00 0.63
SECONDARY
Change in Serum Lactate
0.12; 0.20 0.86
SECONDARY
Change in Creatinine Clearance
0; 0 0.55
SECONDARY
Change in P:F Ratio
6.5; 0.05 0.55
SECONDARY
Change in Dynamic Compliance
2.30; 1.20 0.48
SECONDARY
Change in Troponins
-0.04; -0.09 0.04 sig
SECONDARY
Pulsatile Perfusion Flow
98.58; 89.42; 105.28; 104.03; 117.98; 94.21 0.53
SECONDARY
Six Month Hospital Free Survival of All Organ Recipients
172; 171 0.97
SECONDARY
Delayed Graft Function (DGF) of Kidney Recipients.
45; 51; 202; 184 0.07
SECONDARY
Pulsatile Perfusion Parameters
0.29; 0.38; 0.25; 0.31; 0.22; 0.33 0.006 sig

Summary

The purpose of this study is to determine whether application of lower limb remote ischemic preconditioning (RIPC) after determination of brain death improves donor stability, organ quality, organ yield, and early post transplant clinical outcomes. Neurological death donors will be stratified into standard and extended criteria donors (SCD/ECD) and randomized in a 1:1 fashion to RIPC or No intervention. The primary outcome is the number of organs recovered per donor. Secondary outcomes include donor hemodynamic state, donor organ-specific function parameters, pulsatile perfusion parameters, number of organs transplanted per donor, recipient hospital free survival and delayed graft function of kidneys. The sample size is powered to detect a difference of 0.44 organs recovered.

Eligibility Criteria

Inclusion Criteria

  • Neurological death donors in whom brain death determination is imminent
  • First person consent or next of kin consent for research
  • Donors >=6 years of age
  • Organ recovery not expected within 6 hours of consent.
  • Both sexes and ethnicities.

Exclusion Criteria

  • Donation after cardiac death donors (DCD)
  • Live organ donors
  • No first person consent and next of kin decline research consent
  • Donor Age < 6 years
  • Lower extremity trauma or recent amputation
  • Tissue only donors
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT01515072). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search